W David Arnold - Myotonic Dystrophy Overview and Update
Cardiovascular manifestations of Myotonic Dystrophy
Ligand for Potential Treatment of Myotonic Dystrophy Type 1 (DM1) | UIUC Office of Technology Management
Entrada Therapeutics | Myotonic Dystrophy Type 1 (DM1)
RNA toxic gain-of-function model for DM1 pathogenesis. Mutant DMPK RNA... | Download Scientific Diagram
Additional molecular pathogenetic mechanisms in DM1. Results suggest an... | Download Scientific Diagram
Frontiers | Muscle wasting in myotonic dystrophies: a model of premature aging
Myotonic dystrophy — Knowledge Hub
New myotonic dystrophy type 1 mouse model | Cell Research
IJMS | Free Full-Text | Disrupting the Molecular Pathway in Myotonic Dystrophy
Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the DMPK gene: Molecular Therapy - Nucleic Acids
Myotonic dystrophy: Emerging mechanisms for DM1 and DM2 - ScienceDirect
Gene Therapy and Gene Editing for Myotonic Dystrophy | SpringerLink
Myotonic dystrophy - Wikipedia
Entrada Therapeutics | Myotonic Dystrophy Type 1 (DM1)
Figure 1 from Myotonic Dystrophy Type 1 (DM1): From the Genetics to Molecular Mechanisms | Semantic Scholar
Projects
Novel mouse model of myotonic dystrophy displays reversible cardiac disease features of the condition
Model for the molecular consequences of triplet expansion in DM1. In... | Download Scientific Diagram
DM1-AS Gene - GeneCards | DM1-AS RNA Gene
Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions
DM1 pathogenetic mechanisms and therapeutic strategies. The actions of... | Download Scientific Diagram
Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics - Chau - 2015 - Developmental Dynamics - Wiley Online Library
